AXSOME THERAPEUTICS INC (AXSM:NASDAQ)
$182.97 -5.72 (-3.0314%)
Analysed AXSOME THERAPEUTICS INC (AXSM:NASDAQ) News Sources
Axsome Therapeutics Facing 'Attractive Setup' Ahead of Auvelity's Label Expansion Decision, Oppenheimer Says
21-04-2026
yahoo.com
Four Biotech Stocks Near Buy Points As Earnings Season Kicks In
17-04-2026
yahoo.com
Biotech Stock Knocks At $2 Billion Opportunity, Nears Buy Point
16-04-2026
yahoo.com
Is Axsome Therapeutics (AXSM) Still Attractively Priced After Its 72% One-Year Surge
13-04-2026
yahoo.com
Axsome Faces Key Auvelity FDA Call And Insider Sentiment Test
12-04-2026
yahoo.com
Axsome Therapeutics Upside Tied to Auvelity FDA Decision, $2 Billion Sales Opportunity Seen, UBS Says
10-04-2026
yahoo.com
Is This Healthcare Stock a Millionaire Maker?
08-04-2026
fool.com
Axsome Therapeutics to Report First Quarter 2026 Financial Results on May 4
08-04-2026
yahoo.com
Axsome Therapeutics Acquires Selective PDE10A Inhibitor Balipodect for the Treatment of Schizophrenia and Other Neuropsychiatric Conditions
01-04-2026
yahoo.com
Axsome Therapeutics (AXSM) Valuation Check After Recent Share Price Cooling
30-03-2026
yahoo.com
What is the current price of AXSOME THERAPEUTICS INC (AXSM:NASDAQ)?
The current price of AXSOME THERAPEUTICS INC (AXSM:NASDAQ) is $182.97.
AXSOME THERAPEUTICS INC (AXSM:NASDAQ) absolute price change since previous trading day?
The absolute price change of AXSOME THERAPEUTICS INC (AXSM:NASDAQ) since the previous trading day is $-5.72.
AXSOME THERAPEUTICS INC (AXSM:NASDAQ) percentage price change since previous trading day?
The percentage price change of AXSOME THERAPEUTICS INC (AXSM:NASDAQ) since the previous trading day is -3.0314%.
What is the most recent average sentiment score for AXSOME THERAPEUTICS INC (AXSM:NASDAQ)?
The most recent average sentiment score for AXSOME THERAPEUTICS INC (AXSM:NASDAQ) is 90 out of 100.
What is the most recent average sentiment for AXSOME THERAPEUTICS INC (AXSM:NASDAQ)?
The most recent sentiment for AXSOME THERAPEUTICS INC (AXSM:NASDAQ) is .
SEC-8K** Filing Available For AXSOME THERAPEUTICS INC (AXSM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.